NEK2 and neoplasm: Previous studies have identified abnormal levels of NEK2 proteins in a series of tumors, and NEK2 is involved in cell growth and apoptosis, enhances the ability of tumor invasion, and reduces the sensitivity of tumor cells to chemotherapeutic agents, thereby contributing to the tumorigenic capacity of malignant tumors [22, 23].